Results 81 to 90 of about 767,972 (297)

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Interpretation of guideline on "Post⁃stroke cognitive impairment"

open access: yesHuli yanjiu, 2022
This paper interpreted key contents in guideline on "Post⁃stroke cognitive impairment",in order to provide standardized guidance for clinical work in China and improve quality of life of patients.
CUI Qian   +4 more
doaj  

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

open access: yesMolecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen   +19 more
wiley   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Indian Consensus Guidelines for the Management of Pancreatic Cancer

open access: yesIndian Journal of Medical and Paediatric Oncology
Pancreatic cancer needs a multidisciplinary approach to treatment. These consensus statements encompass all aspects of treatment of pancreatic cancer within the Indian context. This article outlines consensus-based Indian guidelines for pancreatic cancer
Viraj Lavingia   +14 more
doaj   +1 more source

Irish oral health services guideline initiative. Oral health assessment: Best practice guidance for providing an oral health assessment programme for school-aged children in Ireland. 2012 [PDF]

open access: yes, 2012
In the Republic of Ireland, the Health Service Executive (HSE), which is the national authority responsible for health and personal social services, has statutory responsibility to make dental services available, free of charge, to children under the ...
Guideline Development Group
core  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Author Guidelines

open access: yesAfrican Journal of Information & Communication Technology, 2006
This document guides would be authors of papers for review in the AJICT on how to write their papers to meet the requirements for submissions, reviews and publications in the ...
openaire   +18 more sources

Diagnosis and staging of patients with ovarian cancer National Clinical Guideline No. 20: Summary

open access: yes, 2019
This summary should be read in conjunction with the full version National Clinical Guideline. The full version is available at: https://health.gov.ie/national-patient-safety-office/ncec/national-clinical-guidelines/. The complete list of appendices can
Department of Health
core  

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy